Entegris
ENTG · NasdaqPlastics Products, NEC · Fiscal year ends Dec 31
Entegris reported revenue of $3.2B in the fiscal year ended Dec 2025, down 1.4% from the year before. Operating income was $456M, an operating margin of 14.3%, and net income was $236M. Operating cash flow of $695M less capital expenditure of $299M left free cash flow of $396M. Net debt was $3.3B.
Last 5 fiscal years
Revenue and net income
Income statement
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | $2.3B | $3.3B | $3.5B | $3.2B | $3.2B |
| Cost of revenue | $1.2B | $1.9B | $2B | $1.8B | $1.8B |
| Gross profit | $1.1B | $1.4B | $1.5B | $1.5B | $1.4B |
| Research & development | $168M | $229M | $277M | $316M | $329M |
| Selling, general & admin | $292M | $543M | $576M | $447M | $451M |
| Operating income | $552M | $480M | $499M | $534M | $456M |
| Interest expense | $41M | $213M | $312M | $215M | $200M |
| Pre-tax income | $479M | $247M | $173M | $322M | $255M |
| Income tax | $70M | $38M | −$8M | $28M | $18M |
| Net income | $409M | $209M | $181M | $293M | $236M |
| Diluted EPS | 3.00 | 1.46 | 1.20 | 1.93 | 1.55 |
| Diluted shares | 137M | 143M | 151M | 152M | 152M |
Balance sheet
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $403M | $563M | $457M | $329M | $360M |
| Receivables | – | – | – | – | $459M |
| Inventory | $475M | $813M | $607M | $638M | $643M |
| Current assets | $1.3B | $2.3B | $2B | $1.6B | $1.6B |
| Net PP&E | $654M | $1.4B | $1.5B | $1.6B | $1.6B |
| Goodwill | $794M | $4.4B | $3.9B | $3.9B | $3.9B |
| Total assets | $3.2B | $10.1B | $8.8B | $8.4B | $8.4B |
| Payables | $131M | $172M | $134M | $193M | $172M |
| Deferred revenue | $23M | $60M | $69M | $42M | $50M |
| Current liabilities | $379M | $762M | $514M | $525M | $489M |
| Short-term debt | $0 | $152M | $0 | $0 | $0 |
| Long-term debt | $937M | $5.6B | $4.6B | $4B | $3.7B |
| Shareholders' equity | $1.7B | $3.2B | $3.4B | $3.7B | $4B |
Cash flow
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $400M | $363M | $645M | $632M | $695M |
| Capital expenditure | $211M | $466M | $457M | $316M | $299M |
| Free cash flow | $190M | −$103M | $188M | $316M | $396M |
| Depreciation & amortisation | $138M | $135M | $173M | $188M | $205M |
| Stock-based compensation | $30M | $67M | $61M | $66M | $69M |
| Acquisitions | $92M | $4.5B | $0 | $0 | – |
| Share buybacks | $67M | $0 | $0 | – | – |
| Dividends paid | $44M | $57M | $60M | $61M | $61M |
| Dividend per share | 0.32 | 0.40 | 0.40 | 0.40 | 0.40 |
Key ratios
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 42.8% | 7.4% | −8.0% | −1.4% |
| Operating income growth (YoY) | – | −13.0% | 4.0% | 7.0% | −14.6% |
| EPS growth (YoY) | – | −51.3% | −17.8% | 60.8% | −19.7% |
| Gross margin | 46.1% | 42.5% | 42.5% | 45.9% | 44.4% |
| Operating margin | 24.0% | 14.6% | 14.2% | 16.5% | 14.3% |
| Net margin | 17.8% | 6.4% | 5.1% | 9.0% | 7.4% |
| Return on equityBlank when equity is negative | 23.9% | 6.5% | 5.3% | 7.9% | 6.0% |
| ROCEEBIT ÷ (assets − current liabilities) | 19.6% | 5.1% | 6.0% | 6.8% | 5.8% |
| Free cash flow margin | 8.3% | −3.1% | 5.3% | 9.8% | 12.4% |
| Cash conversion (CFO ÷ net income) | 0.98x | 1.74x | 3.57x | 2.16x | 2.95x |
| Receivable days | – | – | – | – | 52 |
| Inventory days | 140 | 157 | 109 | 133 | 132 |
| Payable days | 39 | 33 | 24 | 40 | 35 |
| Interest cover | 13.4x | 2.26x | 1.60x | 2.48x | 2.28x |
| Debt ÷ equity | 0.55x | 1.80x | 1.34x | 1.08x | 0.94x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | $534M | $5.2B | $4.1B | $3.7B | $3.3B |
| Current ratio | 3.47x | 3.06x | 3.85x | 3.08x | 3.35x |
Recent filings
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.